Table 1.
Pre-clinical diabetic retinopathy (haemodynamic and hystopathological abnormalities) | Clinical diabetic retinopathy (clinically visible lesions) | Severe diabetic retinopathy (pre-proliferative and proliferative diabetic retinopathy) |
---|---|---|
ET-1 increased | ET-1 decreased | ET-1 and ET-3 increased |
Activation of ECs/pericytes and mitogenic effect on VSMCs | Reduced action on pericytes and VSMCs | Upregulation of ECs, pericytes, and VSMCs |
Increased extent of microangiopathy | Capillary dilation, microaneurysms, and fluid leakage | Capillary occlusion, ischemia, and neovascularization |
Actions of ET system over ECs/pericytes/VSMCs and structural changes in diabetic retinal tissue
ECs endothelial cells, ET-1 endothelin-1, ET-3 endothelin-3, VSMCs vascular smooth muscle cells